Anyone here willing to give ZFGN a second chance? The way they handled the blowup of beloranib makes me not want to have anything to do with this company, however, if P1 data looks good ...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.